Medical Device News Magazine

Vitastem Ultra: Helping Hospitals & Nursing Homes Combat HAIs

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Infections in healthcare facilities such as hospitals and nursing homes have become a significant issue in the past decade, and even more so, the past several years now. The problem of hospital-acquired infections (HAIs) is prevalent, and it is growing even more so by the day. These infections happen as patients come into contact with bacteria, viruses, and fungi in healthcare facilities, which can lead to severe health risks, complications, and even death.

MRSA and Staphylococcus infections are two of the most common culprits that cause severe HAIs. However, there is hope in the form of Vitastem Ultra – an FDA-registered, patent-pending, new, and incredibly innovative topical antibiotic spray that can help hospitals and nursing homes drastically reduce the risk of HAIs and protect their patients from dangerous infections pretty quickly with more widespread usage of it.

1. What is Vitastem Ultra?

Vitastem Ultra is an innovative topical antibiotic spray that helps treat wounds more effectively and reduce HAIs in healthcare facilities like hospitals, surgery centers, and nursing homes. This unique product contains a potent combination of several natural antibiotics that work together to mainly fight off minor to more severe bacteria like staph & MRSA (flesh-eating bacteria) but has proved to be effective at treating viruses like herpes zoster (shingles), and fungi (finger & toenail fungus). This means that Vitastem Ultra can effectively kill the harmful bacteria that cause MRSA and staph infections – two of the most common pathogens found in healthcare facilities that accelerate HAIs globally.

2. The benefits of using Vitastem Ultra

The use of Vitastem Ultra in hospitals and nursing homes can reduce the risk of HAIs dramatically. By applying their antibiotic spray on the skin, it helps to kill, neutralize, or suppress the growth of harmful bacteria such as MRSA and Staph. Vitastem Ultra helps to promote skin wellness, prevent infections, protect against MRSA, and reduce costly medical visits for patients. It is an essential tool to help fight infections and keep healthcare facilities safe for everyone.

3. How Vitastem Ultra Works

Vitastem Ultra represents a new generation of topical antibiotics that do not destroy the body’s natural gut microbiome, unlike traditional oral antibiotics that can cause more significant issues, including bacterial resistance. This topical antibiotic spray is proven to be extremely effective at penetrating the skin to provide a nurturing environment to rebuild damaged cells, increase blood flow, and provide the necessary nutrients to combat HAI-causing bacteria.

4. Safe to Use for All Age Groups

Vitastem Ultra is entirely safe to use, and its usage is not limited to hospitals and nursing homes; it is available over the counter (OTC) for home use. It is a Class-1 medical product, meaning it’s in the safest of all medical categories. There are no known side effects of using Vitastem Ultra, making it a safe and appropriate treatment for everyone, including people with sensitive skin. It is recommended to apply the product two to three times a day, depending on the severity of the infection.

5. The Future of Vitastem Ultra

Vitastem Ultra is a proven effective solution for combatting the rise of HAIs, as its application reduces the chance of serious medical complications for patients, staff, and visitors. With the ever-increasing concern of rising antibiotic resistance super bugs, the use of Vitastem Ultra is becoming more important every day in helping to combat challenging skin infections. Routine usage in hospitals and nursing homes can help stop the spread of existing infections, reduce healing time, and protect patients from any secondary infections that have been known to prolong hospital stays and even death.

In conclusion, Vitastem Ultra is a very powerful and incredibly innovative topical antibiotic that can help protect patients in healthcare facilities from HAIs with way better wound care treatment options. With the ever-growing concern of antibiotic resistance and the need for infection control, it is clear that Vitastem Ultra is the future of infection protection and control. The product is safe to use, effective, and can readily fit into any infection prevention framework. By using Vitastem Ultra to help combat HAIs, hospitals, and nursing homes can reduce additional infections, prolonged hospital stays, and serious health risks like sepsis and death, creating safer environments for all their patients.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”